In the world of predictive and preventive healthcare, one name stands out - David Quinney, co-founder of FHIOS (BioTech Health Technologies). In this blog, we explore David's background, his entrepreneurial journey, and the groundbreaking work FHIOS is doing to reshape the American healthcare landscape.
A native of Salt Lake City, Utah, David's entrepreneurial spirit took root during his college years at the University of Miami, where he double-majored in psychology and marketing. His first business venture, started with close friends during college, set the stage for a career marked by creativity and innovation.
After graduation, David ventured to sunny California, where he became a serial entrepreneur, establishing himself in finance and manufacturing. Despite the challenges he faced during the 2008-09 financial crisis, David's resilience and problem-solving skills were honed, laying the foundation for future endeavors.
In 2010, he co-founded a media and technology company in Los Angeles that pioneered digital and social marketing strategies for iconic brands such as Toyota, Walt Disney and the LA Lakers. While no longer actively running the company, David continues to serve as Chairman and oversees various creative projects. His journey into angel investing and technology entrepreneurship set the stage for a pivotal moment in 2017.
In 2017, David made his first foray into healthcare investing, igniting a passion that would lead to the birth of FHIOS. Despite initial setbacks, the experience was invaluable and laid the groundwork for David and his three co-founders - Dr. Uzochi Erlingsson, MD (a biochemical clinical geneticist), Dr. Erik Erlingsson, MD, MS, MPH (a Ph.D. in public health), and Chris Poulin (a leading AI expert)-to reimagine the American healthcare system.
The original founding team was assembled in 2019, and began a two-year research and development process to develop breakthrough protocols. Now with an expanded team of founding partners, FHIOS stands at the intersection of predictive and preventative health, promising a paradigm shift in healthcare.
David Quinney introduces FHIOS as a predictive and preventive disease screening system, a comprehensive healthcare system in your pocket. The FHIOS approach is unique in that it focuses on keeping individuals healthy for as long as possible, with the goal of extending the time before individuals enter the medical system.
FHIOS used a statistical modeling approach to identify the top 10 causes of illness and death, later expanding to the top 50. The screening protocol incorporates diverse data sets - genomics, molecular biota, microbiome, family health history, and personal/environmental factors. The result is a rich individual data set that facilitates early detection and proactive health management.
After two and a half years of intensive research and development, FHIOS developed a proprietary genomic panel that surpasses existing genomic tests. With advanced blood panels, microbiome analysis, and personal/environmental questionnaires, the challenge was to productize this science. FHIOS achieved a breakthrough by delivering a comprehensive protocol (excluding the imaging study) to your home or office in as little as 15 minutes.
Imagine a doctor's visit without the inconvenience - schedule a health baseline through the FHIOS app, and a health professional will collect samples at your chosen location. After five days of lab processing and AI analysis, a 60- to 90-minute consultation with a Files Precision Physician awaits. This can be done virtually or in person, putting members in control of their health journey.
David emphasizes that FHIOS isn't trying to replace your current doctor, but to provide a rich data set and ongoing knowledge about your internal health. The Health Data Vault securely stores all records for easy access, making healthcare fun, convenient and affordable.
FHIOS provides access to a precision physician through a network of over 4,000 physicians nationwide. Its partnership with Uber Doc ensures same-day appointments with top-notch physicians. The Files platform includes Files Virtual, which offers curated health and wellness products, and Files Life, which turns your city into a personal health club by identifying the best facilities.
Currently founder-funded, FHIOS has announced two rounds of funding - a $1 million seed round at a $10 million valuation and an A round to reach 14 markets in 36 months. David expresses a commitment to reward early partners and investors with a significantly lower valuation as they scale.
David's journey from entrepreneurship to healthcare innovation exemplifies the spirit of FHIOS. By focusing on predictive and preventative health, FHIOS is poised to redefine the healthcare landscape. David's passion for extending the time before individuals enter the medical system underscores FHIOS' commitment to providing the best outcomes for its members. As FHIOS continues to revolutionize health screenings and expand its reach, the vision of a healthier future is one step closer to reality. Stay tuned for the next chapter in this transformative healthcare journey.
Click HERE to listen to an insightful podcast with David Quinney, co-founder of FHIOS (BioTech Health Technologies), hosted by Ron Costa and Vickie Huchmala of Mapable US. Gain valuable insights into the future of healthcare and FHIOS' revolutionary approach.
PhilanthroInvestors combines traditional venture capital financing tools with philanthropic principles to achieve social impact. By secure, meaningful, and profitable investments, they bring capital and also change people’s lives.
PhilanthroInvestors are currently working in four sectors – Housing, Water, Health and Environment – and will be adding more investment sectors in the future. PhilanthroInvestors founder Ivan Anz owns companies on three continents and has investors in 14 countries.
Discover how investing with us can secure your future. Get in touch here.
© 2024 l PhilanthroWealth LLC®
THE CONTENT OF THIS SITE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES.